Arterial stiffness: A nexus between cardiac and renal disease

CardioRenal Medicine

Volumn 4, Issue 1, 2014, Pages 60-71

  Jia, Guanghong ^a,b,c,d   Aroor, Annayya R ^a,b,d   Sowers, James R ^a,b,c,d  

^a Novo Nordisk   (United States)

^b Diabetes Cardiovascular Center   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Arterial stiffness; Cardiorenal metabolic syndrome; Endothelial cells; Estrogen; Vascular smooth muscle cells

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALDOSTERONE; ANGIOTENSINOGEN; C REACTIVE PROTEIN; COLLAGEN; CYCLIC GMP; ELASTIN; ESTROGEN; ESTROGEN RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN RECEPTOR SUBSTRATE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MANGANESE SUPEROXIDE DISMUTASE; MATRIX METALLOPROTEINASE; NITRIC OXIDE; PADGEM PROTEIN; PEROXYNITRITE; PHOSPHATIDYLINOSITOL 3 KINASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SERUM AMYLOID A; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR; TRANSCRIPTION FACTOR RUNX2; TUMOR NECROSIS FACTOR ALPHA; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ARTERIAL STIFFNESS; ARTERY INJURY; BLOOD VESSEL CALCIFICATION; CARDIORENAL SYNDROME; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CORONARY ARTERY BLOOD FLOW; DETERIORATION; DIASTOLIC DYSFUNCTION; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; GLOMERULOSCLEROSIS; HEART DISEASE; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERURICEMIA; INFLAMMATION; INSULIN RESISTANCE; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEINURIA; PULSE WAVE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SEX DIFFERENCE; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE; ADAPTIVE IMMUNITY; BLOOD VESSEL WALL; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENDOTHELIUM CELL; ENZYME ACTIVATION; HEART CONTRACTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FUNCTION; KIDNEY BLOOD FLOW; MOLECULAR BIOLOGY; OXIDATION; PATHOPHYSIOLOGY; REGULATORY MECHANISM; RENOVASCULAR DISEASE; TIGHT JUNCTION; VASCULAR DISEASE;

EID: 84898013419     PISSN: 16643828     EISSN: 16645502     Source Type: Journal    
DOI: 10.1159/000360867     Document Type: Review

References (60)

1. Aroor AR, McKarns S, Demarco VG, Jia G, Sowers JR: Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance. Metabolism 2013; 62: 1543-1552.
2. Aroor AR, Demarco VG, Jia G, Sun Z, Nistala R, Meininger GA, Sowers JR: The Role of Tissue Renin-Angiotensin- Aldosterone System in the Development of Endothelial Dysfunction and Arterial Stiffness. Front Endocrinol (Lausanne) 2013; 4: 161.
3. Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM, Vita JA, Levy D, Benjamin EJ: Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation 2010; 121: 505-511.
4. Luft FC: Molecular mechanisms of arterial stiffness: new insights: J Am Soc Hypertens 2012; 6: 436-438.
5. Vlachopoulos C, Aznaouridis K, Stefanadis C: Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010; 55: 1318-1327.
6. The Reference Values for Arterial Stiffness Collaboration: Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: establishing normal and reference values. Eur Heart J 2010; 31: 2338-2350.
7. Sowers JR: Diabetes mellitus and vascular disease. Hypertension 2013; 61: 943-947.
8. Briet M, Boutouyrie P, Laurent S, London GM: Arterial stiffness and pulse pressure in CKD and ESRD. Kidney Int 2012; 82: 388-400.
9. Tomiyama H, Tanaka H, Hashimoto H, Matsumoto C, Odaira M, Yamada J, Yoshida M, Shiina K, Nagata M, Yamashina A: Arterial stiffness and declines in individuals with normal renal function/early chronic kidney disease. Atherosclerosis 2010; 212: 345-350.
10. Liew Y, Rafey MA, Allam S, Arrigain S, Butler R, Schreiber M: Blood pressure goals and arterial stiffness in chronic kidney disease. J Clin Hypertens (Greenwich) 2009; 11: 201-206.
11. Wang X, Keith JC Jr, Struthers AD, Feuerstein GZ: Assessment of arterial stiffness, a translational medicine biomarker system for evaluation of vascular risk. Cardiovasc Ther 2008; 26: 214-223.
12. Cote AT, Bredin SS, Phillips AA, Koehle MS, Glier MB, Devlin AM, Warburton DE: Left ventricular mechanics and arterial-ventricular coupling following high-intensity interval exercise. Appl Physiol (1985) 2013; 115: 1705-1713.
13. Antonini-Canterin F, Carerj S, Di Bello V, Di Salvo G, La Carrubba S, Vriz O, Pavan D, Balbarini A, Nicolosi GL; Research Group of the Italian Society of Cardiovascular Echography (SIEC): Arterial stiffness and ventricular stiffness: a couple of diseases or a coupling disease? A review from the cardiologists point of view. Eur J Echocardiogr 2009; 10: 36-43.
14. Hummel SL, Seymour EM, Brook RD, Sheth SS, Ghosh E, Zhu S, Weder AB, Kovcs SJ, Kolias TJ: Low-sodium DASH diet improves diastolic function and ventricular-arterial coupling in hypertensive heart failure with preserved ejection fraction. Circ Heart Fail 2013; 6: 1165-1171.
15. Chen CH, Lin YP, Yu WC, Yang WC, Ding YA: Volume status and blood pressure during long-term hemodialysis: role of ventricular stiffness. Hypertension 2003; 42: 257-262.
16. Siekmeier R, Grammer T, Mrz W: Roles of oxidants, nitric oxide, and asymmetric dimethylarginine in endothelial function. J Cardiovasc Pharmacol Ther 2008; 13: 279-297.
17. Muniyappa R, Sowers JR: Endothelial insulin and IGF-1 receptors: when yes means NO. Diabetes 2012; 61: 2225-2227.
18. Rask-Madsen C, Kahn CR: Tissue-specific insulin signaling, metabolic syndrome, and cardiovascular disease. Arterioscler Thromb Vasc Biol 2012; 32: 2052-2059.
19. Doronzo G, Russo I, Mattiello L, Anfossi G, Bosia A, Trovati M: Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: influence of nitric oxide and of insulin resistance. Eur J Clin Invest 2004; 34: 664-673. (Pubitemid 39423024)
20. Speer MY, Yang HY, Brabb T, Leaf E, Look A, Lin WL, Frutkin A, Dichek D, Giachelli CM: Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries. Circ Res 2009; 104: 733-741.
21. Johnson RC, Leopold JA, Loscalzo J: Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res 2006; 99: 1044-1059. (Pubitemid 44729928)
22. Schiffrin EL, Lipman ML, Mann JF: Chronic kidney disease: effects on the cardiovascular system. Circulation 2007; 116: 85-97. (Pubitemid 47016250)
23. Jia G, Stormont RM, Gangahar DM, Agrawal DK: Role of matrix Gla protein in angiotensin II-induced exacerbation of vascular calcification. Am J Physiol Heart Circ Physiol 2012; 303:H523-H532.
24. van Bussel BC, Schouten F, Henry RM, Schalkwijk CG, de Boer MR, Ferreira I, Smulders YM, Twisk JW, Stehouwer CD: Endothelial dysfunction and low-grade inflammation are associated with greater arterial stiffness over a 6-year period. Hypertension 2011; 58: 588-595.
25. Ait-Oufella H, Salomon BL, Potteaux S, Robertson AK, Gourdy P, Zoll J, Merval R, Esposito B, Cohen JL, Fisson S, Flavell RA, Hansson GK, Klatzmann D, Tedgui A, Mallat Z: Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 2006; 12: 178-180. (Pubitemid 43214743)
26. He S, Li M, Ma X, Lin J, Li D: CD4+CD25+Foxp3+ regulatory T cells protect the proinflammatory activation of human umbilical vein endothelial cells. Arterioscler Thromb Vasc Biol 2010; 30: 2621-2630.
27. Patel RS, Al Mheid I, Morris AA, Ahmed Y, Kavtaradze N, Ali S, Dabhadkar K, Brigham K, Hooper WC, Alexander RW, Jones DP, Quyyumi AA: Oxidative stress is associated with impaired arterial elasticity. Atherosclerosis 2011; 218: 90-95.
28. Zhou RH, Vendrov AE, Tchivilev I, Niu XL, Molnar KC, Rojas M, Carter JD, Tong H, Stouffer GA, Madamanchi NR, Runge MS: Mitochondrial oxidative stress in aortic stiffening with age: the role of smooth muscle cell function. Arterioscler Thromb Vasc Biol 2012; 32: 745-755.
29. Sell DR, Monnier VM: Molecular basis of arterial stiffening: role of glycation - a mini-review. Gerontology 2012; 58: 227-237.
30. Wang M, Jiang L, Monticone RE, Lakatta EG: Proinflammation: the key to arterial aging. Trends Endocrinol Metab 2014; 25: 72-79.
31. Chung AW, Yang HH, Sigrist MK, Brin G, Chum E, Gourlay WA, Levin A: Matrix metalloproteinase-2 and -9 exacerbate arterial stiffening and angiogenesis in diabetes and chronic kidney disease. Cardiovasc Res 2009; 84: 494-504.
32. Whaley-Connell A, Sowers JR: Oxidative stress in the cardiorenal metabolic syndrome. Curr Hypertens Rep 2012; 14: 360-365.
33. Kim JA, Jang HJ, Martinez-Lemus LA, Sowers JR: Activation of mTOR/p70S6 kinase by ANG II inhibits insulinstimulated endothelial nitric oxide synthase and vasodilation. Am J Physiol Endocrinol Metab 2012; 302:E201-E208.
34. Castorena-Gonzalez JA, Staiculescu MC, Foote CA, Polo Parada L, Martinez-Lemus LA: The obligatory role of the actin cytoskeleton on inward remodeling induced by dithiothreitol activation of endogenous transglutaminase in isolated arterioles. Am J Physiol Heart Circ Physiol 2013, Epub ahead of print.
35. Weisbrod RM, Shiang T, Al Sayah L, Fry JL, Bajpai S, Reinhart-King CA, Lob HE, Santhanam L, Mitchell G, Cohen RA, Seta F: Arterial stiffening precedes systolic hypertension in diet-induced obesity. Hypertension 2013; 62: 1105-1110.
36. Thomas WG: Double trouble for type 1 angiotensin receptors in atherosclerosis. N Engl J Med 2005; 352: 506-508. (Pubitemid 40175980)
37. Ferro CJ, Steeds RP, Townend JN: Hypertension, arterial haemodynamics and left ventricular disease: historical observations. QJM 2012; 105: 709-716.
38. Tsuchikura S, Shoji T, Kimoto E, Shinohara K, Hatsuda S, Koyama H, Emoto M, Nishizawa Y: Central versus peripheral arterial stiffness in association with coronary, cerebral and peripheral arterial disease. Atherosclerosis 2010; 211: 480-485.
39. Hsu PC, Tsai WC, Lin TH, Su HM, Voon WC, Lai WT, Sheu SH: Association of arterial stiffness and electrocardiography- determined left ventricular hypertrophy with left ventricular diastolic dysfunction. PLoS One 2012; 7:e49100.
40. Borlaug BA, Paulus WJ: Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur Heart J 2011; 32: 670-679.
41. Dey NB, Lincoln TM: Possible involvement of Cyclic-GMP-dependent protein kinase on matrix metalloproteinase- 2 expression in rat aortic smooth muscle cells. Mol Cell Biochem 2012; 368: 27-35.
42. Deenadayalu V, Puttabyatappa Y, Liu AT, Stallone JN, White RE: Testosterone-induced relaxation of coronary arteries: activation of BKCa channels via the cGMP-dependent protein kinase. Am J Physiol Heart Circ Physiol 2012; 302:H115-H123.
43. Weir MR, Townsend RR, Fink JC, Teal V, Anderson C, Appel L, Chen J, He J, Litbarg N, Ojo A, Rahman M, Rosen L, Sozio SM, Steigerwalt S, Strauss L, Joffe MM: Hemodynamic correlates of proteinuria in chronic kidney disease. Clin J Am Soc Nephrol 2011; 6: 2403-2410.
44. Grassi D, Ferri C: Aortic stiffness, blood pressure and renal dysfunction. Intern Emerg Med 2011; 6(suppl 1):111-114.
45. Ford ML, Tomlinson LA, Chapman TP, Rajkumar C, Holt SG: Aortic stiffness is independently associated with rate of renal function decline in chronic kidney disease stages 3 and 4. Hypertension 2010; 55: 1110-1115.
46. Long DA, Price KL, Herrera-Acosta J, Johnson RJ: How does angiotensin II cause renal injury? Hypertension 2004; 43: 722-723.
47. Wang C, Zhang J, Li CC, Gong WY, Liu X, Ye ZC, Peng H, Lou TQ: The ambulatory arterial stiffness index and target-organ damage in Chinese patients with chronic kidney disease. BMC Nephrol 2013; 14: 257.
48. Townsend RR, Wimmer NJ, Chirinos JA, Parsa A, Weir M, Perumal K, Lash JP, Chen J, Steigerwalt SP, Flack J, Go AS, Rafey M, Rahman M, Sheridan A, Gadegbeku CA, Robinson NA, Joffe M: Aortic PWV in chronic kidney disease: a CRIC ancillary study. Am J Hypertens 2010; 23: 282-289.
49. Annavarajula SK, Dakshinamurty KV, Naidu MU, Reddy CP: The effect of L-arginine on arterial stiffness and oxidative stress in chronic kidney disease. Indian J Nephrol 2012; 22: 340-346.
50. Russo C, Jin Z, Palmieri V, Homma S, Rundek T, Elkind MS, Sacco RL, Di Tullio MR: Arterial stiffness and wave reflection: sex differences and relationship with left ventricular diastolic function. Hypertension 2012; 60: 362-368.
51. Manrique C, DeMarco VG, Aroor AR, Mugerfeld I, Garro M, Habibi J, Hayden MR, Sowers JR: Obesity and insulin resistance induce early development of diastolic dysfunction in young female mice fed a Western diet. Endocrinology 2013; 154: 3632-3642.
52. Gaspard U: Hyperinsulinaemia, a key factor of the metabolic syndrome in postmenopausal women. Maturitas 2009; 62: 362-365.
53. Duprez D, Jacobs DR Jr: Arterial stiffness and left ventricular diastolic function: does sex matter? Hypertension 2012; 60: 283-284.
54. Regitz-Zagrosek V, Brokat S, Tschope C: Role of gender in heart failure with normal left ventricular ejection fraction. Prog Cardiovasc Dis 2007; 49: 241-251. (Pubitemid 44932176)
55. Coutinho T, Borlaug BA, Pellikka PA, Turner ST, Kullo IJ: Sex differences in arterial stiffness and ventriculararterial interactions. J Am Coll Cardiol 2013; 61: 96-103.
56. Prabhushankar R, Krueger C, Manrique C: Membrane estrogen receptors: their role in blood pressure regulation and cardiovascular disease. Curr Hypertens Rep 2014; 16: 408.
57. Masood DE, Roach EC, Beauregard KG, Khalil RA: Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease. Curr Drug Metab 2010; 11: 693-714.
58. Miller VM, Duckles SP: Vascular actions of estrogens: functional implications. Pharmacol Rev 2008; 60: 210-241. (Pubitemid 351962010)
59. Pettersson US, Waldn TB, Carlsson PO, Jansson L, Phillipson M: Female mice are protected against high-fat diet induced metabolic syndrome and increase the regulatory T cell population in adipose tissue. PLoS One 2012; 7:e46057.
60. Lee SA, Kim EY, Jeon WK, Woo CH, Choe J, Han S, Kim BC: The inhibitory effect of raloxifene on lipopolysaccharide- induced nitric oxide production in RAW264.7 cells is mediated through a ROS/p38 MAPK/CREB pathway to the up-regulation of heme oxygenase-1 independent of estrogen receptor. Biochimie 2011; 93: 168-174.